Multivessel Coronary Artery Disease: Clinical Trials

3 trials for Multivessel Coronary Artery Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated, 1 unknown, 1 withdrawn. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Terminated 1, Unknown 1, Withdrawn 1

Follow Multivessel Coronary Artery Disease: new trials by email Literature Review of Multivessel Coronary Artery Disease trials Research Report on Multivessel Coronary Artery Disease

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Residual Inflammatory Risk-Guided colcHicine in Elderly Trial
colchicine - Percutaneous Coronary Intervention, Multivessel Coronary Artery Disease
Phase 4UnknownChinese Academy of Medical Sciences, Fuwai Hospital8002023-09-012023-09-06
A Multicentre, Pilot Study to Evaluate the Safety and the Feasibility of Planning and Execution of Surgical Revascularization in Patients With Complex Coronary Artery Disease, Based Solely on MSCT Imaging Utilizing GE Healthcare Revolution CT and HeartFlow FFRCT.
Multi-sliced computed tomography (MSCT) - Multivessel Coronary Artery Disease
Phase 4WithdrawnECRI bv2019-06-282019-12-06
Revascularization With BVS or CABG in Patients With Advanced CAD
PCI -BVS, CABG - Multivessel Coronary Artery Disease
Phase 4TerminatedPoznan University of Medical Sciences112015-02-012016-11-28

Interventions

Colchicine (1)

Sponsors

Chinese Academy of Medical Sciences, Fuwai Hospital (1)  ·  ECRI bv (1)  ·  Poznan University of Medical Sciences (1)

Countries

Belgium (1)  ·  China (1)  ·  Germany (1)  ·  Italy (1)  ·  Poland (1)  ·  Switzerland (1)

Top investigators

Maciej Lesiak, MD, PhD (1)  ·  Patrick W Serruys, Prof. dr. (1)  ·  Xueyan Zhao, M.D. (1)